Authors

• Yuji Takahashi (ORCID: https://orcid.org/0000-0002-5606-7576)
• Eiko Nakano Minakawa (ORCID: https://orcid.org/0000-0002-6204-9104)
• Tomohiko Ishihara (ORCID: https://orcid.org/0000-0001-9915-8665)
• Takanori Yokota (ORCID: https://orcid.org/0000-0002-6490-3263)
• Kinya Ishikawa (ORCID: https://orcid.org/0000-0003-3999-2855)
• Yoshitomi Kanemitsu (ORCID: https://orcid.org/0000-0002-0209-224X)
• Koichi Saito (ORCID: https://orcid.org/0000-0001-6497-5286)
• Yoshitaka Nagai (ORCID: https://orcid.org/0000-0003-1037-3129)
• Masayoshi Tada
• Kensuke Ikenaka
• Osamu Onodera (ORCID: https://orcid.org/0000-0003-3354-5472)
• Makito Hirano (ORCID: https://orcid.org/0000-0003-0759-1627)

Institutions

• Osaka Gakuin University (JP)
• Tokyo Medical and Dental University (JP)
• National Center of Neurology and Psychiatry (JP)
• Niigata City General Hospital (JP)
• Niigata University Medical and Dental Hospital (JP)
• Niigata University (JP)
• Kindai University (JP)
• The University of Osaka (JP)

Publication Details

Journal

EClinicalMedicine

Published

2024-11-25

DOI

https://doi.org/10.1016/j.eclinm.2024.102952

Citations

5

Primary Topic

Genetic Neurodegenerative Diseases

Type

article

Field-Weighted Citation Impact

1.34

Funders

• EA Pharma Co., Ltd.
• Ministry of Health, Labour and Welfare